MediMix Oncology
  • Home
  • Congresses
    • 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
      • ESMO GI 2024
      • ASCO 2024
      • JFHOD 2024
      • ASCO GU 2024
      • ESGO & SGO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
ESMO 2023GI

Cell line study of nucleosome-based biomarkers in the diagnosis and detection of relapses in glioblastoma

28 October 2023

Jonathan Decarpentrie, PhD researcher at the university of Namur presented his project focusing on the detection of epigenetic modifications of nucleosomes in glioblastoma by means of the Nu. Q® technology tool.

 

 

You may also be interested in:

The AVETUXIRI phase II study

27 October 2023

R-IMMUNE study: atezolizumab in locally advanced rectal cancer

26 October 2023

Prognosis in stage II colorectal cancer: The effect of the primary tumor location and biomarkers

25 October 2023

With the educational support of:

Tags:

poster

Share Article

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Congresses
    • 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
      • ESMO GI 2024
      • ASCO 2024
      • JFHOD 2024
      • ASCO GU 2024
      • ESGO & SGO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok